Topic
Acute fatty liver of pregnancy
💡 What You Need to Know
- Rare but Severe Condition: Acute fatty liver of pregnancy (AFLP) is a life-threatening obstetric emergency characterized by microvesicular fatty infiltration of hepatocytes.
- Typical Onset: Usually manifests in the third trimester of pregnancy or early postpartum period.
- Underlying Mechanism: Often associated with a fetal genetic defect in fatty acid oxidation, such as long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
- Urgent Intervention Required: Prompt diagnosis and immediate delivery are crucial for maternal and fetal survival.
🤒 Associated Symptoms
- Early Gastrointestinal Symptoms: Profound nausea, persistent vomiting, and epigastric or right upper quadrant abdominal pain.
- Systemic Manifestations: Malaise, headache, and progressive fatigue.
- Liver Dysfunction Signs: Jaundice (yellowing of skin and eyes), dark urine, and pruritus (itching).
- Neurological Changes: Encephalopathy, confusion, lethargy, and in severe cases, coma.
- Other Complications: Polyuria, polydipsia (due to diabetes insipidus), acute pancreatitis, and signs of coagulopathy (e.g., easy bruising, bleeding).
🛡 Crucial Precautions
- High Index of Suspicion: Maintain a high clinical suspicion for AFLP in any pregnant woman presenting with new-onset gastrointestinal symptoms, jaundice, or altered mental status in late pregnancy.
- Prompt Diagnostic Workup: Immediately initiate laboratory investigations including liver function tests, coagulation profile, renal function, electrolytes, and blood glucose.
- Differential Diagnosis: Carefully differentiate AFLP from other conditions like HELLP syndrome, severe pre-eclampsia, and viral hepatitis, as management differs.
- Continuous Monitoring: Ensure continuous maternal vital sign monitoring, neurological assessment, and fetal surveillance (cardiotocography).
- Avoid Liver Biopsy if Coagulopathic: Liver biopsy, while definitive, is often deferred if significant coagulopathy is present due to bleeding risk; clinical and laboratory criteria usually suffice.
🍽 Dietary Directions & Restrictions
- NPO Status: Patients are typically kept nil per os (NPO) due to severe nausea, vomiting, and the high likelihood of requiring urgent delivery or surgical intervention.
- Intravenous Hydration: Aggressive intravenous fluid resuscitation with dextrose-containing solutions is essential to correct dehydration and manage hypoglycemia.
- Electrolyte Management: Close monitoring and correction of electrolyte imbalances, particularly potassium and phosphate.
- Post-Delivery Reintroduction: Gradual reintroduction of oral fluids and a light diet may commence only after clinical stabilization and improvement in liver function, under strict medical supervision.
- Nutritional Support: In cases of prolonged liver dysfunction or severe catabolism, parenteral nutrition may be required.
⚠️ Attendant Guidelines
- Multidisciplinary Team: Management requires a coordinated effort from obstetricians, intensivists, hepatologists, neonatologists, and anesthesiologists.
- Expedited Delivery: Once diagnosed or strongly suspected, immediate delivery of the fetus is the definitive treatment, regardless of gestational age.
- Coagulopathy Management: Be prepared to administer fresh frozen plasma (FFP), cryoprecipitate, and platelets to correct coagulopathy and prevent hemorrhage.
- Hypoglycemia Protocol: Implement a strict protocol for monitoring and managing hypoglycemia, which can be profound and lead to neurological damage.
- Postpartum Surveillance: Close monitoring in an intensive care setting is critical for several days postpartum, as liver function may continue to deteriorate before improvement.
🩺 Physician's Perspective
- Diagnostic Confirmation: Diagnosis relies on a constellation of clinical symptoms, characteristic laboratory abnormalities (e.g., elevated transaminases, bilirubin, prolonged PT/INR, hypoglycemia), and exclusion of other conditions.
- Management Priority: The primary goals are to stabilize the mother, correct metabolic derangements, and achieve prompt delivery to halt disease progression.
- Fetal Considerations: Fetal distress is common due to maternal illness; neonatal risks include prematurity, hypoglycemia, and potential LCHAD deficiency.
- Recurrence Risk: The risk of recurrence in subsequent pregnancies is low unless an underlying genetic defect (e.g., LCHAD) is identified in the mother or father, necessitating genetic counseling.
- Long-term Follow-up: Maternal liver function typically recovers completely, but long-term follow-up is important to ensure full resolution and screen for any residual complications.
🎓 Academic & Nursing Corner
- Comprehensive Assessment: Perform frequent neurological assessments for signs of encephalopathy, monitor for bleeding, and assess abdominal pain characteristics.
- Fluid and Electrolyte Balance: Meticulously track intake and output, monitor urine specific gravity, and administer IV fluids and electrolytes as prescribed.
- Medication Administration: Administer dextrose infusions, vitamin K, and blood products (FFP, platelets) accurately and monitor for adverse reactions.
- Patient and Family Support: Provide clear, empathetic communication to the patient and family regarding the severity of the condition and the urgent need for intervention.
- Postpartum Care: Continue close monitoring of vital signs, liver function, and signs of recovery or complications; support breastfeeding if the mother is stable and desires.
🔬 Clinical Reference Index
- Pathophysiology: Characterized by microvesicular steatosis of hepatocytes, often linked to defects in mitochondrial beta-oxidation of fatty acids, particularly LCHAD deficiency.
- Swansea Criteria: A set of diagnostic criteria (e.g., vomiting, abdominal pain, polydipsia/polyuria, encephalopathy, jaundice, hypoglycemia, elevated AST/ALT, bilirubin, PT, urea, leukocytosis, ascites, bright liver on ultrasound) used to aid in diagnosis.
- Key Complications: Disseminated intravascular coagulation (DIC), acute renal failure, pancreatitis, hepatic encephalopathy, and high maternal and fetal mortality rates without timely intervention.
- Genetic Linkage: Consider genetic testing for LCHAD deficiency in the infant and parents, as it can identify carriers and inform future pregnancy risks.
- Management Principles: Aggressive supportive care, correction of metabolic derangements, and immediate delivery are the cornerstones of treatment.